Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Astria Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 111 | 1 | 116 | +6 |
| Shares | 58.5M | 103.5K | 58.3M | −120.4K (−0.2%) |
| Value | $523.4M | $925.4K | $311.4M | −$211.0M (−40.4%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Astria Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 179,161 | $956.7K | 0.00% |
| Nuveen, LLC | 103,517 | $552.8K | 0.00% |
| Gsa Capital Partners LLP | 67,174 | $359.0K | 0.03% |
| ExodusPoint Capital Management, LP | 36,906 | $197.0K | 0.00% |
| Fox Run Management, L.L.C. | 34,320 | $183.3K | 0.03% |
| Jump Financial, LLC | 33,305 | $177.8K | 0.00% |
| Balyasny Asset Management LLC | 28,984 | $154.8K | 0.00% |
| Graham Capital Management, L.P. | 20,841 | $111.3K | 0.00% |
| Virtus Investment Advisers, Inc. | 16,735 | $89.4K | 0.02% |
| Quantinno Capital Management LP | 16,621 | $88.8K | 0.00% |
| Corton Capital Inc. | 13,534 | $72.3K | 0.24% |
| Susquehanna Fundamental Investments, LLC | 11,051 | $59.0K | 0.00% |
| Axq Capital, LP | 10,299 | $55.0K | 0.02% |
| CIBC World Markets Corp | 10,269 | $54.8K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 6,715 | $35.9K | 0.01% |
| Point72 (DIFC) Ltd | 3,525 | $18.8K | 0.00% |
| Farther Finance Advisors, LLC | 1,914 | $10.3K | 0.00% |
| Allworth Financial LP | 277 | $1.44K | 0.00% |
| Signaturefd, LLC | 241 | $1.29K | 0.00% |
Sold out (13)
Institutions that held Astria Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| UBS Oconnor LLC | 129,666 | $1.16M |
| Patient Square Capital LP | 105,057 | $939.2K |
| Rafferty Asset Management, LLC | 37,571 | $335.9K |
| Group One Trading, L.P. | 32,290 | $288.7K |
| Connor, Clark & Lunn Investment Management Ltd. | 22,160 | $198.1K |
| Two Sigma Investments, LP | 19,428 | $173.7K |
| State of Wisconsin Investment Board | 15,322 | $137.0K |
| Engineers Gate Manager LP | 12,069 | $107.9K |
| Teacher Retirement System of Texas | 10,125 | $91.0K |
| Virtus ETF Advisers LLC | 7,247 | $64.8K |
| SRS Capital Advisors, Inc. | 65 | $582 |
| The PNC Financial Services Group, Inc. | 10 | $89 |
| Macquarie Group Ltd | 4,658 | $42 |
Not filed for Q1 2025 yet (1)
Institutions that held Astria Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 103,517 | $925.4K |